Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib plus Tivantinib vs Chemotherapy in KRAS+ NSCLC
NCT01395758Phase 2Completed
- Start
- Jul 2011
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tivantinib in non-small cell lung cancer (NSCLC). Started Jul 2011; status: completed.
02
Drugs
tivantinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01395758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01395758.